InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: murocman post# 1298

Wednesday, 06/20/2012 1:29:52 PM

Wednesday, June 20, 2012 1:29:52 PM

Post# of 16750
From PPS point of view, we will be closer to $20 once the results come out Q4 this year. The $1 billon market potential for this treatment will attract big pharma players driving the price probably higher. I see MDVN like move soon when it jumped from below 20 to 40+ in November last year and it's been parabolic since then....